Mark L. Berch

Array ( [id] => 6945300 [patent_doc_number] => 20050197349 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'Pyrrolo[2,3-D]pyrimidine compounds' [patent_app_type] => utility [patent_app_number] => 11/112307 [patent_app_country] => US [patent_app_date] => 2005-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19387 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20050197349.pdf [firstpage_image] =>[orig_patent_app_number] => 11112307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5880592 [patent_doc_number] => 20060029674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Stable amorphous Cefdinir' [patent_app_type] => utility [patent_app_number] => 11/103183 [patent_app_country] => US [patent_app_date] => 2005-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 4456 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20060029674.pdf [firstpage_image] =>[orig_patent_app_number] => 11103183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7056444 [patent_doc_number] => 20050277619 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-15 [patent_title] => 'Novel purine inhibitors of fructose-1,6-bisphosphatase' [patent_app_type] => utility [patent_app_number] => 11/101807 [patent_app_country] => US [patent_app_date] => 2005-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 29388 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 48 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0277/20050277619.pdf [firstpage_image] =>[orig_patent_app_number] => 11101807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6953081 [patent_doc_number] => 20050228176 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Process for the preparation of tazobactam in pure form' [patent_app_type] => utility [patent_app_number] => 11/098526 [patent_app_country] => US [patent_app_date] => 2005-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2147 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20050228176.pdf [firstpage_image] =>[orig_patent_app_number] => 11098526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6931796 [patent_doc_number] => 20050282831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Selective antagonists of A2A adenosine receptors' [patent_app_type] => utility [patent_app_number] => 11/097251 [patent_app_country] => US [patent_app_date] => 2005-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27656 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282831.pdf [firstpage_image] =>[orig_patent_app_number] => 11097251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4720335 [patent_doc_number] => 20080242858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Process For the Preparation of Cefixime' [patent_app_type] => utility [patent_app_number] => 10/598877 [patent_app_country] => US [patent_app_date] => 2005-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2670 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20080242858.pdf [firstpage_image] =>[orig_patent_app_number] => 10598877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5063663 [patent_doc_number] => 20070225303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => '8-Oxoadenine Compound' [patent_app_type] => utility [patent_app_number] => 10/594074 [patent_app_country] => US [patent_app_date] => 2005-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42990 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20070225303.pdf [firstpage_image] =>[orig_patent_app_number] => 10594074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4634513 [patent_doc_number] => 08012964 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-06 [patent_title] => '9-substituted 8-oxoadenine compound' [patent_app_type] => utility [patent_app_number] => 10/593691 [patent_app_country] => US [patent_app_date] => 2005-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42949 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/012/08012964.pdf [firstpage_image] =>[orig_patent_app_number] => 10593691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7070113 [patent_doc_number] => 20050245498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Sterically-awkward beta-lactamase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/083151 [patent_app_country] => US [patent_app_date] => 2005-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11030 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20050245498.pdf [firstpage_image] =>[orig_patent_app_number] => 11083151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6960052 [patent_doc_number] => 20050215781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Novel polymorph of cefdinir' [patent_app_type] => utility [patent_app_number] => 11/079180 [patent_app_country] => US [patent_app_date] => 2005-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4109 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20050215781.pdf [firstpage_image] =>[orig_patent_app_number] => 11079180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7138419 [patent_doc_number] => 20050182077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Xanthine phosphodiesterase V inhibitors' [patent_app_type] => utility [patent_app_number] => 11/078999 [patent_app_country] => US [patent_app_date] => 2005-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15444 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20050182077.pdf [firstpage_image] =>[orig_patent_app_number] => 11078999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4977958 [patent_doc_number] => 20070219191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => '3-Pyridinium Methyl Cephem Compound' [patent_app_type] => utility [patent_app_number] => 10/591398 [patent_app_country] => US [patent_app_date] => 2005-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11763 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20070219191.pdf [firstpage_image] =>[orig_patent_app_number] => 10591398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7111755 [patent_doc_number] => 20050209211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Trihemihydrate, anhydrate and novel hydrate forms of Cefdinir' [patent_app_type] => utility [patent_app_number] => 11/072568 [patent_app_country] => US [patent_app_date] => 2005-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4340 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20050209211.pdf [firstpage_image] =>[orig_patent_app_number] => 11072568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5113643 [patent_doc_number] => 20070197559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-23 [patent_title] => 'Aryl substituted purine analogues' [patent_app_type] => utility [patent_app_number] => 10/591553 [patent_app_country] => US [patent_app_date] => 2005-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24771 [patent_no_of_claims] => 92 [patent_no_of_ind_claims] => 39 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20070197559.pdf [firstpage_image] =>[orig_patent_app_number] => 10591553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8146472 [patent_doc_number] => 08163479 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'Specific substrates for O6-alkylguanine-DNA alkyltransferase' [patent_app_type] => utility [patent_app_number] => 10/591162 [patent_app_country] => US [patent_app_date] => 2005-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20101 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163479.pdf [firstpage_image] =>[orig_patent_app_number] => 10591162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5131775 [patent_doc_number] => 20070208172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-06 [patent_title] => 'Process for Preparing Cephalosporin Intermediates Using Alpha-Iodo-1-Azetidineacetic Acid Esters and Trialkylphosphites' [patent_app_type] => utility [patent_app_number] => 10/592201 [patent_app_country] => US [patent_app_date] => 2005-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6038 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20070208172.pdf [firstpage_image] =>[orig_patent_app_number] => 10592201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7051338 [patent_doc_number] => 20050187225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Process for the production of N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide (zaleplon)' [patent_app_type] => utility [patent_app_number] => 11/067044 [patent_app_country] => US [patent_app_date] => 2005-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4176 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20050187225.pdf [firstpage_image] =>[orig_patent_app_number] => 11067044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5247855 [patent_doc_number] => 20070244089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => '2- Arylmethylazetidine Carbapenem Derivatives and Preparation Thereof' [patent_app_type] => utility [patent_app_number] => 11/578007 [patent_app_country] => US [patent_app_date] => 2005-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11148 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20070244089.pdf [firstpage_image] =>[orig_patent_app_number] => 11578007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6912939 [patent_doc_number] => 20050176697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Phosphonocephem compound' [patent_app_type] => utility [patent_app_number] => 11/063715 [patent_app_country] => US [patent_app_date] => 2005-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17626 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176697.pdf [firstpage_image] =>[orig_patent_app_number] => 11063715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 185367 [patent_doc_number] => 07645763 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-12 [patent_title] => '8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical composition' [patent_app_type] => utility [patent_app_number] => 11/062518 [patent_app_country] => US [patent_app_date] => 2005-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7494 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/645/07645763.pdf [firstpage_image] =>[orig_patent_app_number] => 11062518 [rel_patent_id] =>[rel_patent_doc_number] =>)